BBOTVSLABT• 6 Months (Normalized)
BBOT vs LABT (BridgeBio Oncology Therapeutics Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Apr 9 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.6
-59.35%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
LABT Performance $0.85
-99.01%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+39.66 pts
BBOT outperforming by 39.66 percentage points
BBOTLABT
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | BBOT Price | BBOT Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $3.60 | -59.35% | $0.85 | -99.01% | +39.66% |
| Oct 02, 2026 | $3.89 | -56.07% | $0.93 | -98.92% | +42.85% |
| Sep 30, 2026 | $4.10 | -53.70% | $- | - | |
| Sep 29, 2026 | $3.92 | -55.73% | $0.99 | -98.86% | +43.13% |
| Sep 28, 2026 | $3.81 | -56.97% | $1.15 | -98.67% | +41.70% |
| Sep 25, 2026 | $3.95 | -55.39% | $1.67 | -98.07% | +42.68% |
| Sep 24, 2026 | $3.99 | -54.94% | $1.83 | -97.88% | +42.94% |
| Sep 23, 2026 | $4.16 | -53.02% | $1.78 | -97.94% | +44.92% |
| Sep 22, 2026 | $4.66 | -47.37% | $1.99 | -97.70% | +50.33% |
| Sep 21, 2026 | $4.66 | -47.37% | $2.05 | -97.63% | +50.26% |
| Sep 18, 2026 | $4.77 | -46.13% | $1.99 | -97.70% | +51.57% |
| Sep 17, 2026 | $4.89 | -44.78% | $1.86 | -97.85% | +53.07% |
| Sep 16, 2026 | $4.76 | -46.25% | $2.09 | -97.58% | +51.33% |
| Sep 15, 2026 | $4.88 | -44.89% | $2.17 | -97.49% | +52.60% |
| Sep 14, 2026 | $5.05 | -42.97% | $2.12 | -97.55% | +54.58% |
Page 1 of 9